|
Semiquantitative parameters
|
Total
|
EPD +
|
EPD−
|
p-value
|
|---|
|
SUVmax(mean ± SD)
|
14.2 ± 10
|
16.7 ± 10.4
|
12.4 ± 9.2
|
0.081
|
|
PSMAvol(mean ± SD)
|
6.7 ± 8.4
|
10.4 ± 10.7
|
3.9 ± 4.2
|
0.004
|
|
PSMAtot(mean ± SD)
|
53.2 ± 82.5
|
86.7 ± 109.5
|
28.4 ± 37.1
|
0.008
|
|
ADCmin(mean ± SD)
|
0.534* ± 0.252
|
0.525** ± 0.209
|
0.539 ± 0.276
|
0.818
|
|
ADCmean(mean ± SD)
|
0.942* ± 0.232
|
0.922** ± .218
|
0.956 ± 0.238
|
0.546
|
|
mpMRI LCC (mean ± SD)
|
20.4 ± 16.5
|
26.6 ± 18.9
|
15.8 ± 12.6
|
0.009
|
|
mpMRI volume (mean ± SD)
|
3.0 ± 6.0
|
4.3 ± 8
|
2.1 ± 3.6
|
0.162
|
- Statistically significant p-values are marked by bold font
- EPD extraprostatic disease, SUV standardized uptake value, max maximum, min minimum, SD standard deviation, ADC apparent diffusion coefficient, LCC longest capsular contact
- *72/73 patients assessable
- **30/31 patients assessable
